Skip to main content
. 2012 Sep;87(9):825–834. doi: 10.1016/j.mayocp.2012.05.014

FIGURE 1.

FIGURE 1

The REVEAL (Registry to Evaluate Early and Long-term Pulmonary Arterial Hypertension Disease Management) study population comprising patients exposed to intravenous (IV) prostanoid therapy for ≥1 day. BSI = bloodstream infection.